ARCHIVES

Pittsburgh Broadens Misconduct Inquiry

This article is from The Cancer Letter archive.

Vol. 20 No. 22 | June 3, 1994

Download PDF Visit The Full Archive

Related Articles

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

MRI Contract: AACI Group Still Seething

August 8, 1986

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

Four UICC Programs Available For International Research

July 10, 1981

New Jersey Insurers To Cover Patient Care Costs In Trials.

January 14, 2000

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000